Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at increased risk of developing heart failure.
Heart Failure Prevention Study
Age Range:
40 to 100
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
This study is looking at whether an investigational treatment, when added to standard treatment, may help reduce the risk of heart failure and cardiovascular-related death
Qualifications
You May Qualify If You:
- Are 40 years of age or older
- Have type 2 diabetes
- Have cardiovascular disease, such as a history of heart disease, stroke, or circulation problems
- Have additional factors that may put you at higher risk for developing heart failure
- Have not been diagnosed with symptomatic heart failure
Additional eligibility requirements apply.
FEATURED STUDIES
Heart Disease & Inflammation Study
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase
Heart Failure Prevention Study
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Weight & Wellness Research Study Interest
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Flu Prevention Study Interest List
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
General Anxiety Disorder Study
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a
Uncontrolled COPD Study
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a